Skip to main content
Skip to main content
PHR logo

Phreesia, Inc. (PHR)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Phreesia, Inc. (PHR) trades at $9.03 with AI Score 56/100 (Hold). Phreesia, Inc. offers a SaaS-based platform for healthcare organizations, streamlining patient intake and payment processes. Market cap: 549M, Sector: Healthcare.

Last analyzed: Feb 8, 2026
Phreesia, Inc. offers a SaaS-based platform for healthcare organizations, streamlining patient intake and payment processes. Their integrated solutions aim to improve efficiency and patient experience in the healthcare sector.
56/100 AI Score Target $26.50 (+193.5%) MCap 549M Vol 646K

Phreesia, Inc. (PHR) Healthcare & Pipeline Overview

CEOChaim Indig
Employees2082
HeadquartersWilmington, NC, US
IPO Year2019

Phreesia is revolutionizing patient intake with its SaaS platform, offering streamlined workflows and integrated payment solutions for healthcare providers. With a focus on enhancing patient experience and operational efficiency, Phreesia is poised to capitalize on the growing demand for digital health solutions, making it an attractive investment.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Phreesia presents a notable research candidate due to its strong market position and growth potential within the healthcare technology sector. The company's integrated SaaS platform addresses critical needs in patient intake and payment processing, driving efficiency and improving patient experience. With a gross margin of 68.2%, Phreesia demonstrates a solid foundation for profitability as it scales its operations. Key value drivers include the increasing adoption of digital health solutions, expansion into new specialties and healthcare settings, and strategic partnerships with pharmaceutical and medical device companies. The company's focus on innovation and its ability to adapt to evolving healthcare needs position it for sustained growth. As healthcare providers continue to prioritize efficiency and patient engagement, Phreesia is well-positioned to capitalize on these trends.

Based on FMP financials and quantitative analysis

Key Highlights

  • Phreesia's SaaS-based platform streamlines patient intake and payment processes, enhancing efficiency for healthcare providers.
  • The company's gross margin of 68.2% indicates strong profitability potential as it scales its operations.
  • Phreesia serves a diverse range of clients, including single-specialty practices, multi-specialty groups, and health systems.
  • The Phreesia Platform offers a comprehensive suite of solutions, including registration, revenue cycle management, and clinical support.
  • Phreesia's platform supports various modalities, including mobile devices, tablets, and on-site kiosks, providing flexibility for patients and providers.

Competitors & Peers

Strengths

  • Integrated SaaS platform with comprehensive functionality.
  • Strong market position in patient intake and payment solutions.
  • Diverse customer base across various healthcare segments.
  • High gross margin indicating profitability potential.

Weaknesses

  • Negative profit margin (-1.2%) indicates current unprofitability.
  • High P/E ratio (-134.98) suggests overvaluation or lack of earnings.
  • Reliance on the healthcare industry, making it susceptible to regulatory changes.
  • Limited geographic presence outside of the United States and Canada.

Catalysts

  • Continued adoption of digital health solutions by healthcare providers.
  • Expansion into new medical specialties and healthcare settings.
  • Strategic partnerships with pharmaceutical and medical device companies.
  • Increased utilization of telehealth services.

Risks

  • Competition from established players and emerging startups in the healthcare technology market.
  • Cybersecurity risks and data privacy breaches compromising patient information.
  • Changes in healthcare regulations and reimbursement policies impacting revenue.
  • Negative profit margin and high P/E ratio indicating financial instability.
  • Economic downturns reducing healthcare spending and impacting customer demand.

Growth Opportunities

  • Expansion into New Specialties: Phreesia has the opportunity to expand its platform to support additional medical specialties beyond the current 25. This would involve tailoring the platform's clinical support solution to meet the specific needs of each specialty, including the collection of relevant patient-reported outcome (PRO) data. The addressable market for this expansion is significant, as it encompasses a wide range of medical fields seeking to improve patient care and streamline workflows. This initiative could drive substantial revenue growth and strengthen Phreesia's position as a leading provider of healthcare technology solutions.
  • Strategic Partnerships with Pharmaceutical Companies: Phreesia can leverage its platform to forge strategic partnerships with pharmaceutical companies, offering targeted marketing and patient engagement solutions. By delivering clinically relevant content to patients through the Phreesia Platform, pharmaceutical companies can improve medication adherence and patient outcomes. This represents a significant revenue opportunity for Phreesia, as pharmaceutical companies are increasingly seeking innovative ways to connect with patients and promote their products. These partnerships could also enhance Phreesia's value proposition to healthcare providers by providing access to valuable resources and support.
  • Increased Adoption of Telehealth Solutions: The growing adoption of telehealth presents a significant growth opportunity for Phreesia. The company's platform already supports telehealth visits through features such as contactless check-in and remote intake information collection. As telehealth becomes more prevalent, Phreesia can further enhance its platform to meet the evolving needs of virtual care providers. This includes integrating with telehealth platforms, developing new features for remote patient monitoring, and providing tools for virtual patient engagement. By capitalizing on the telehealth trend, Phreesia can expand its market reach and solidify its position as a leader in healthcare technology.
  • Penetration of the Canadian Market: Phreesia currently operates in both the United States and Canada, but there is significant potential to further penetrate the Canadian market. By tailoring its platform to meet the specific needs of Canadian healthcare providers and patients, Phreesia can capture a larger share of this market. This includes addressing regulatory requirements, integrating with Canadian healthcare systems, and providing localized customer support. The Canadian market represents a valuable growth opportunity for Phreesia, as it offers a stable and well-developed healthcare system with a growing demand for digital health solutions.
  • Development of Advanced Analytics and Reporting Tools: Phreesia can enhance its platform by developing advanced analytics and reporting tools that provide healthcare providers with valuable insights into patient data and operational performance. These tools could help providers identify trends, optimize workflows, and improve patient outcomes. By offering these capabilities, Phreesia can increase the value of its platform and attract new customers. The market for healthcare analytics is growing rapidly, as providers seek to leverage data to improve care delivery and reduce costs. This represents a significant growth opportunity for Phreesia, as it can position itself as a leader in healthcare analytics and data-driven decision-making.

Opportunities

  • Expansion into new medical specialties and healthcare settings.
  • Strategic partnerships with pharmaceutical and medical device companies.
  • Increased adoption of telehealth solutions.
  • Development of advanced analytics and reporting tools.

Threats

  • Competition from established players and emerging startups.
  • Cybersecurity risks and data privacy concerns.
  • Changes in healthcare regulations and reimbursement policies.
  • Economic downturns affecting healthcare spending.

Competitive Advantages

  • Integrated platform offering a comprehensive suite of solutions.
  • Extensive network of healthcare providers and patients.
  • Proprietary technology and data analytics capabilities.
  • Strong brand reputation and customer loyalty.
  • High switching costs due to integration with existing healthcare workflows.

About PHR

Founded in 2005 and headquartered in Raleigh, North Carolina, Phreesia, Inc. has emerged as a leading provider of integrated SaaS-based software and payment solutions for the healthcare industry in the United States and Canada. The company's core offering, the Phreesia Platform, delivers a comprehensive suite of tools designed to modernize and optimize the patient intake process. This platform encompasses various modalities, including Phreesia Mobile for patient mobile devices, Phreesia Dashboard for healthcare client management, PhreesiaPads for self-service intake, and Arrivals Kiosks for on-site check-in. Phreesia's solutions extend beyond basic intake, offering features such as automated patient self-registration, insurance verification, point-of-sale payment processing, and cost estimation tools. The platform also facilitates appointment scheduling, reminders, referral tracking, and the delivery of targeted marketing content from life sciences companies. Furthermore, Phreesia provides clinical support by collecting patient-reported outcome (PRO) data across approximately 25 specialties, enabling healthcare providers to communicate with patients through surveys, announcements, and health campaigns. The company also offers COVID-19 support modules for vaccine management and risk factor screening. Phreesia serves a diverse clientele, including single-specialty practices, multi-specialty groups, health systems, and pharmaceutical, medical device, and biotechnology companies.

What They Do

  • Provides a SaaS-based platform for healthcare organizations.
  • Streamlines patient intake and registration processes.
  • Offers integrated payment solutions for patient payments.
  • Facilitates appointment scheduling and reminders.
  • Delivers targeted marketing content to patients from life sciences companies.
  • Collects clinical intake and patient-reported outcome (PRO) data.
  • Enables communication with patients through surveys, announcements, and health campaigns.

Business Model

  • Subscription fees for access to the Phreesia Platform.
  • Transaction fees for payment processing.
  • Revenue from life sciences companies for targeted marketing campaigns.
  • Fees for additional modules and services, such as advanced analytics and reporting.

Industry Context

Phreesia operates within the rapidly evolving healthcare information services industry, which is experiencing significant growth driven by the increasing adoption of digital health solutions and the need for improved efficiency in healthcare operations. The market is characterized by a mix of established players and emerging startups, all vying to provide innovative solutions for healthcare providers. Competitors include companies like BLFS (BioLife Solutions), ESTA (Establishment Labs Holdings Inc), GDRX (GoodRx Holdings, Inc.), KMTS (KMT Medical Technology), and NEOG (Neogen Corporation). Phreesia differentiates itself through its integrated platform approach, offering a comprehensive suite of solutions that address multiple aspects of the patient intake and payment process.

Key Customers

  • Single-specialty practices.
  • Multi-specialty groups.
  • Health systems.
  • Pharmaceutical companies.
  • Medical device companies.
  • Biotechnology companies.
AI Confidence: 72% Updated: Feb 8, 2026

PHR Financials

PHR Price Today & Live Chart

Phreesia, Inc. (PHR) stock price: $9.03 (-0.12, -1.31%)

PHR Latest News

PHR Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PHR.

Price Targets

Consensus target: $26.50

PHR MoonshotScore

56/100

What does this score mean?

The MoonshotScore rates PHR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

PHR Healthcare Stock FAQ

What does Phreesia, Inc. do?

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry. The company's Phreesia Platform offers a suite of solutions designed to manage the patient intake process, including self-registration, insurance verification, payment processing, and clinical data collection. By streamlining these processes, Phreesia aims to improve efficiency for healthcare providers and enhance the patient experience. The platform is deployed in various modalities, such as mobile devices, tablets, and on-site kiosks, catering to diverse healthcare settings and patient preferences. Phreesia serves a wide range of clients, including single-specialty practices, multi-specialty groups, and health systems.

Is PHR stock worth researching?

PHR stock presents a mixed investment picture. The company's strong market position and innovative platform are attractive, but its current financial metrics raise concerns. While Phreesia boasts a high gross margin of 68.2%, its negative profit margin of -1.2% and high P/E ratio of -134.98 suggest that the company is not yet profitable. Investors should carefully consider the company's growth potential, competitive landscape, and financial stability before making an investment decision. The increasing adoption of digital health solutions and Phreesia's expansion into new markets could drive future growth, but potential risks such as competition and regulatory changes should also be taken into account.

What are the main risks for PHR?

Phreesia faces several key risks that investors should be aware of. The company operates in a competitive market, with established players and emerging startups vying for market share. Cybersecurity risks and data privacy concerns are also significant, as a breach could damage the company's reputation and result in financial losses. Changes in healthcare regulations and reimbursement policies could negatively impact Phreesia's revenue. Additionally, the company's current financial metrics, including a negative profit margin and high P/E ratio, indicate potential financial instability. Economic downturns could also reduce healthcare spending and impact customer demand for Phreesia's solutions.

What are the key factors to evaluate for PHR?

Phreesia, Inc. (PHR) currently holds an AI score of 56/100, indicating moderate score. Analysts target $26.50 (+193% from $9.03). Key strength: Integrated SaaS platform with comprehensive functionality. Primary risk to monitor: Competition from established players and emerging startups in the healthcare technology market. This is not financial advice.

How frequently does PHR data refresh on this page?

PHR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven PHR's recent stock price performance?

Recent price movement in Phreesia, Inc. (PHR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $26.50 implies 193% upside from here. Notable catalyst: Integrated SaaS platform with comprehensive functionality. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider PHR overvalued or undervalued right now?

Determining whether Phreesia, Inc. (PHR) is overvalued or undervalued requires examining multiple metrics. Analysts target $26.50 (+193% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying PHR?

Before investing in Phreesia, Inc. (PHR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Stock data pending update. Financial data is based on the most recent available information.
  • The competitive landscape is subject to change as new players enter the market and existing players evolve their strategies.
Data Sources

Popular Stocks